Business Description
Compare
Compare
Traded in other countries / regions
688428.China33C.Germany09969.Hong KongINCPF.USA IPO Date
2020-03-23Description
InnoCare Pharma Ltd is a commercial-stage biopharmaceutical company. It discovers, develops, and commercializes drugs for the treatment of cancer and autoimmune diseases. Its commercial drug candidate is Orelabrutinib and clinical-stage drug candidates are ICP-192, ICP-105, ICP-723, and others.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.86 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.23 | |||||
| Debt-to-EBITDA | -6.61 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 5.26 | |||||
| Beneish M-Score | 700.98 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 877.8 | |||||
| 3-Year EPS without NRI Growth Rate | 51.2 | |||||
| 3-Year FCF Growth Rate | -100 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.94 | |||||
| 9-Day RSI | 31.95 | |||||
| 14-Day RSI | 31.78 | |||||
| 6-1 Month Momentum % | 6.29 | |||||
| 12-1 Month Momentum % | -28.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 21.08 | |||||
| Quick Ratio | 21.01 | |||||
| Cash Ratio | 20.4 | |||||
| Days Inventory | 37.77 | |||||
| Days Sales Outstanding | 14.14 | |||||
| Days Payable | 196.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.2 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 90.15 | |||||
| Operating Margin % | -17.45 | |||||
| Net Margin % | -23.59 | |||||
| ROE % | -5.13 | |||||
| ROA % | -3.86 | |||||
| ROIC % | -25.6 | |||||
| ROC (Joel Greenblatt) % | -38.93 | |||||
| ROCE % | -3.32 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 8.12 | |||||
| PB Ratio | 1.95 | |||||
| Price-to-Tangible-Book | 1.95 | |||||
| Price-to-Operating-Cash-Flow | 109.47 | |||||
| EV-to-EBIT | -31.93 | |||||
| EV-to-Forward-EBIT | -11.15 | |||||
| EV-to-EBITDA | -39.8 | |||||
| EV-to-Revenue | 6.26 | |||||
| EV-to-Forward-Revenue | 8.43 | |||||
| EV-to-FCF | -26.62 | |||||
| Price-to-Net-Current-Asset-Value | 2.5 | |||||
| Price-to-Net-Cash | 2.62 | |||||
| Earnings Yield (Greenblatt) % | -3.13 |
How InnoCare Pharma Ltd (HKSE:09969) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 1,440.996 | ||
| EPS (TTM) (HK$) | -0.225 | ||
| Beta | 1 | ||
| Volatility % | 69.94 | ||
| 14-Day RSI | 31.78 | ||
| 14-Day ATR (HK$) | 0.475325 | ||
| 20-Day SMA (HK$) | 8.696 | ||
| 12-1 Month Momentum % | -28.32 | ||
| 52-Week Range (HK$) | 7.2 - 15.9 | ||
| Shares Outstanding (Mil) | 1,764.32 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
InnoCare Pharma Ltd Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
InnoCare Pharma Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
InnoCare Pharma Ltd Frequently Asked Questions
What is InnoCare Pharma Ltd(HKSE:09969)'s stock price today?
The current price of HKSE:09969 is HK$8.29. The 52 week high of HKSE:09969 is HK$15.90 and 52 week low is HK$7.20.
When is next earnings date of InnoCare Pharma Ltd(HKSE:09969)?
The next earnings date of InnoCare Pharma Ltd(HKSE:09969) is .
Does InnoCare Pharma Ltd(HKSE:09969) pay dividends? If so, how much?
InnoCare Pharma Ltd(HKSE:09969) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
